Summary
CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins. CytoSorb is also being administered during and after cardiac surgery to prevent post-operative complications such as multiple organ failure. The company offers VetResQ, a blood purification adsorber, to help treat excessive inflammation and toxic injury in animals. The company offers its products through a network of distributors across Europe, the Middle East and Asia Pacific. CytoSorbents is headquartered in Monmouth Junction, New Jersey, the US.
CytoSorbents Corp (CTSO) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
CytoSorbents Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CytoSorbents Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CytoSorbents Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CytoSorbents Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
CytoSorbents Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
CytoSorbents Corp, Medical Equipment, Deal Details 11
Partnerships 11
CytoSorbents Enters into Agreement with Dr. Reddy's Labs 11
CytoSorbents Enters into Distribution Agreement with Armaghan Salamat Kish 11
Terumo Cardiovascular Enters into Agreement with CytoSorbents 12
CytoSorbents Partners with NHLBI for HemoDefend 13
CytoSorbents Enters Into Research Agreement With University of Pennsylvania School Of Veterinary Medicine 13
Equity Offering 14
CytoSorbents Raises USD10 Million in Public Offering of Shares 14
CytoSorbents Completes Private Placement Of Units For US$10.2 Million 16
CytoSorbents Completes Private Placement Of Common Stock For US$4 Million 16
CytoSorbents Completes Private Placement of Common Stock For US$2.9 Million 18
Debt Offering 19
CytoSorbents Completes Private Placement Of Notes Due 2014 For US$1.1 Million 19
CytoSorbents Corp - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Mar 03, 2017: CytoSorbents Reports Record Quarterly and Full-Year 2016 Revenue 23
Jan 10, 2017: CytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results 25
Nov 07, 2016: CytoSorb Q3 2016 Sales Reach Record $2.14M, Doubling From a Year Ago 26
Aug 09, 2016: CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb Sales 27
May 09, 2016: CytoSorbents Continues Strong Growth in Q1 2016 28
Mar 09, 2016: CytoSorbents Reports Record Quarterly and Full-Year 2015 Revenue 31
Corporate Communications 32
Mar 22, 2017: Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins Cytosorbents Scientific Advisory Board 32
Nov 15, 2016: Adrian Thomas Joins CytoSorbents to Drive Western European Sales 33
Product News 34
03/16/2016: CytoSorbents Reports on Successful 3rd International CytoSorb Users Meeting 34
02/26/2016: Data Presented on First CytoSorb Investigator-Initiated Septic Shock Study 35
02/16/2016: CytoSorbents Announces 26th Symposium for Intensive Medicine and Intensive Care Agenda in Bremen, Germany 36
01/21/2016: CytoSorbents Appoints Dr. Volker Humbert as Senior Manager of Clinical Affairs 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
CytoSorbents Corp, Medical Equipment, Key Facts, 2016 1
CytoSorbents Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
CytoSorbents Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CytoSorbents Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CytoSorbents Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CytoSorbents Corp, Deals By Market, 2011 to YTD 2017 9
CytoSorbents Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
CytoSorbents Enters into Agreement with Dr. Reddy's Labs 11
CytoSorbents Enters into Distribution Agreement with Armaghan Salamat Kish 11
Terumo Cardiovascular Enters into Agreement with CytoSorbents 12
CytoSorbents Partners with NHLBI for HemoDefend 13
CytoSorbents Enters Into Research Agreement With University of Pennsylvania School Of Veterinary Medicine 13
CytoSorbents Raises USD10 Million in Public Offering of Shares 14
CytoSorbents Completes Private Placement Of Units For US$10.2 Million 16
CytoSorbents Completes Private Placement Of Common Stock For US$4 Million 16
CytoSorbents Completes Private Placement of Common Stock For US$2.9 Million 18
CytoSorbents Completes Private Placement Of Notes Due 2014 For US$1.1 Million 19
CytoSorbents Corp, Key Competitors 20
CytoSorbents Corp, Key Employees 21
CytoSorbents Corp, Subsidiaries 22
List of Figures
CytoSorbents Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
CytoSorbents Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
CytoSorbents Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
CytoSorbents Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
CytoSorbents Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CytoSorbents Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
CytoSorbents Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CytoSorbents Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 9